John E Wagner MD

Pediatric Hematology & Oncology•Minneapolis, MN

Professor, Pediatrics, University of Minnesota Medical School, Minneapolis

516 Delaware St SEPWB Fifth floor Suite 5100 Clinic 5BMinneapolis, MN 55455
Phone+1 612-626-2663
Fax+1 612-626-4074

Dr. Wagner is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wagner's full profile Already have an account?

Education & Training

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1984 - 1987
Duke University HospitalResidency, Pediatrics, 1981 - 1984
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1981

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MN State Medical License 1991 - 2026
MD State Medical License 1984 - 1991
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Elected Member The American Society for Clinical Investigation, 2000

Clinical Trials

T-Cell Depletion in Unrelated Donor Marrow Transplantation
COMPLETED
PHASE3
Bone Marrow Transplantation in Treating Patients With Leukemia
WITHDRAWN
PHASE3
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
TERMINATED
NA

Publications & Presentations

PubMed

CSF GAG non-reducing ends in MPS IH after peripheral and brain-penetrating therapies: A model comparing IV non-targeted ERT and HCT.
Troy C Lund, John E Wagner, Susie Long, Ashish O Gupta, Paul J Orchard
Molecular Therapy. Advances. 2026-03-12
Increased Vascular Age in Patients with Fanconi Anemia after Hematopoietic Cell Transplantation: Results of a Single-Center Descriptive Analysis.
Meera Srikanthan, Donald R Dengel, Nicholas G Evanoff, Julia Steinberger, Bradley S Miller
Transplantation and Cellular Therapy. 2026-02-01
Tracking Cytopenias in-deficient Fanconi Anemia.
Rochelle R Maxwell, Tamar Berger, Caroline S Jiang, Allana Rosenberg, Ashlyn-Maree Gonzalez
Medrxiv. 2025-12-18

Abstracts/Posters

Outcomes of Chronic Graft-Versus-Host Disease (cGVHD) Following Matched Sibling Donor (MSD) Versus Umbilical Cord Blood Transplant (UCBT)
John E. Wagner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Mgta-456, an Aryl Hydrocarbon Receptor (AHR) Antagonist Based Expansion of CD34+ Hematopoietic Stem Cells (HSC), Permits Selection of Better HLA Matched Cord Blood Uni...
John E. Wagner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Romiplostim Improves Platelet Recovery after UCB Transplant
John E. Wagner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

Top Doctors: A Legacy of DiscoveryJuly 1st, 2021

Grant Support

Off-the-Shelf Immune Effector Cells for Hematological MalignanciesUNIVERSITY OF MINNESOTA1997–2028
Inducible Regulatory T Cells for the Prevention and Treatment of GVHDNational Heart, Lung and Blood Institute2012–Present
First in Human Study to Evaluation the Safety and Tolerability of HSC835Novartis2011–Present
Production Assistance for Cellular TherapiesNational Heart, Lung and Blood Institute2003–Present
Biology and Transplantation of the Human Stem CellNational Cancer Institute1997–Present